|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
1993-1-15
|
|
pubmed:abstractText |
Protein C inhibitor (PCI) inhibits tissue kallikrein by forming stable 1:1 complexes (k1 = 2.3 x 10(4)M-1s-1). Heparin inhibits the tissue kallikrein/PCI-interaction and complex formation of 125I-tissue kallikrein in serum. 125I-tissue kallikrein complexes formed in plasma can be immunoprecipitated with monoclonal anti-PCI IgG suggesting that PCI might be identical to the kallikrein binding protein described previously (J. Chao et al. 1986, Biochem. J. 239, 325-331).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0379-0363
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
38 ( Pt 1)
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
182-9
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
|
|
pubmed:year |
1992
|
|
pubmed:articleTitle |
Possible identity of kallikrein binding protein with protein C inhibitor.
|
|
pubmed:affiliation |
Laboratory for Clinical Experimental Physiology, University of Vienna, Austria.
|
|
pubmed:publicationType |
Journal Article,
In Vitro
|
